| A Different Way to Kill Bacteria: Experimental Peptide Targets MDR Pathogens |
| Wednesday, September 02, 2026 11:20 AM |
| Bacteria have learned to evade many of our antibiotics. But what about defenses shaped by millions of years of evolution? An experimental peptide derived from the human immune protein CXCL10 targets resistant pathogens by exploiting a distinct bacterial vulnerability. The research is early, but the strategy could have implications far beyond a single drug candidate. Read more. |